Pfizer/Ligand's Lasofoxifene Is First "Next-Generation" SERM Filed At FDA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet